HRZN
Horizon Technology Finance Corporation
There isn't enough reported data to score HRZN yet.
JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
HRZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| N/A | |
| N/A |
HRZN's revenue is currently healthy, and its profitability is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like HRZN.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
HRZN PE Valuation
HRZN has no meaningful PE right now: it lost money over the past year.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
HRZN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect HRZN's revenue to grow, but its profitability to weaken.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over HRZN on the outlook, with more favorable earnings and profitability expectations.
HRZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.74 | — |
| Q3 2026 | -$0.65 | +$0.04 |
| Q2 2026 | $0.46 | +$1.51 |
| Q1 2026 | $0.53 | +$0.72 |
| Q4 2025 | -$0.06 | -108% |
| Q3 2025 | -$0.69 | -196% |
| Q2 2025 | -$1.05 | -213% |
| Q1 2023 | $1.36 | +9.7% |
| Q4 2022 | $1.06 | -24% |
HRZN is still losing money, but less than at its worst: $0.65 per share over the past year, against $1.05 at its worst in mid-2025.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over HRZN on earnings quality, reporting a profit while its opponent remains loss making.
HRZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2022 | $13M | +16% |
| Q1 2022 | $8.3M | -16% |
| Q4 2021 | $7.1M | +19% |
| Q3 2021 | $17.1M | +12099% |
| Q2 2021 | $11.1M | -2.2% |
| Q1 2021 | $10M | +303% |
| Q4 2020 | $6M | -41% |
HRZN has the stronger quarterly revenue trend. Revenue is up 16% for HRZN versus up 8.1% for JPM.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2022 | 60% | -1.3 points |
| Q1 2022 | 43% | -18 points |
| Q4 2021 | 35% | -8.6 points |
| Q3 2021 | 75% | +2397 points |
| Q2 2021 | 61% | -8.6 points |
| Q1 2021 | 61% | +90 points |
| Q4 2020 | 44% | -25 points |
| Q3 2020 | -2321% | N/A |
HRZN's operating margin was 60% last quarter, down 1.3 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
HRZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2M | -98% |
| Q2 2026 | $123.5M | +149% |
| Q1 2026 | -$42.1M | -$28.9M |
| Q4 2025 | -$30.4M | -$4.3M |
| Q3 2025 | $50.6M | +$78.9M |
| Q2 2025 | $49.6M | -8.6% |
| Q1 2025 | -$13.2M | -426% |
| Q4 2024 | -$26.1M | -333% |
HRZN has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
HRZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.1% | +1.3M shares |
| 1 year | +61% | +25.1M shares |
| 3 years | +123% | +36.6M shares |
| 5 years | +234% | +46.5M shares |
| Available history | +347% | +51.5M shares |
HRZN has 66M diluted shares, up 61% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $10M |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over HRZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
HRZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | 11.5x | High |
| Q1 2022 | 9.1x | High |
| Q4 2021 | 7.7x | High |
| Q3 2021 | 8.3x | High |
| Q2 2021 | 15.5x | High |
| Q1 2021 | 12.6x | High |
| Q4 2020 | 25.3x | High |
| Q3 2020 | 11.9x | High |
HRZN's net debt is about 12 years of its operating earnings (EBITDA), down from 16 years a year ago. Net leverage isn't a meaningful measure for financial services companies like HRZN.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
HRZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.5 | Neutral |
| Stochastic | 12.2 | Oversold |
HRZN's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
HRZN PE vs Financial Services Sector
| Metric | HRZN | Sector median | Relative |
|---|---|---|---|
| PE | 8.9x | 13x | 32% below |
| PE % | 14 | 63 | 49 pts below |
HRZN has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
HRZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.23 | 11% below |
| 20 week MA | $4.51 | 17% below |
| 50 week MA | $4.95 | 24% below |
| 100 week MA | $6.40 | 41% below |
| 200 week MA | $9.08 | 59% below |
HRZN is in a downtrend: it's below all five of its weekly moving averages, and 59% below its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over HRZN on trend strength, trading above more of its moving averages.
HRZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.4 | $13.0 | +4.9% |
| 2021 | $13.0 | $15.8 | +22% |
| 2022 | $15.8 | $11.6 | -26% |
| 2023 | $11.6 | $13.2 | +13% |
| 2024 | $13.2 | $9.00 | -32% |
| 2025 | $9.00 | $6.34 | -30% |
| 2026 YTD | $6.34 | $3.76 | -41% |
HRZN has finished lower in three of the last six years. It's down 41% so far in 2026.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over HRZN on returns for 2026, with the stronger performance.